Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
Ao Huang, Xin Zhao, Xin–Rong Yang, et al.
Journal of Hepatology (2017) Vol. 67, Iss. 2, pp. 293-301
Closed Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Caldéraro, Gabrielle Couchy, Sandrine Imbeaud, et al.
Journal of Hepatology (2017) Vol. 67, Iss. 4, pp. 727-738
Closed Access | Times Cited: 645
Targeted therapy for hepatocellular carcinoma
Ao Huang, Xin–Rong Yang, Wen Yuan Chung, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 556
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Sandra Rebouissou, Jean–Charles Nault
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 215-229
Open Access | Times Cited: 438
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Robin Kate Kelley, et al.
Nature Cancer (2022) Vol. 3, Iss. 4, pp. 386-401
Open Access | Times Cited: 286
Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
Qi Zhang, Yu Lou, Jiaqi Yang, et al.
Gut (2019) Vol. 68, Iss. 11, pp. 2019-2031
Open Access | Times Cited: 271
An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte–tumor cell crosstalk, local immunosuppression and tumor progression
Liang Wu, Jiayan Yan, Yinqi Bai, et al.
Cell Research (2023) Vol. 33, Iss. 8, pp. 585-603
Open Access | Times Cited: 104
Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma
Brandon M. Lehrich, Josephine Zhang, Satdarshan P. Monga, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 3, pp. 515-530
Open Access | Times Cited: 47
Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
Xiaolin Wu, Jiahui Li, Asmae Gassa, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 9, pp. 1551-1562
Open Access | Times Cited: 130
Liquid biopsy in the clinical management of hepatocellular carcinoma
Johann von Felden, Teresa García‐Lezana, Kornelius Schulze, et al.
Gut (2020) Vol. 69, Iss. 11, pp. 2025-2034
Closed Access | Times Cited: 116
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
Ismaïl Labgaa, Carlos Villacorta-Martín, Delia D’Avola, et al.
Oncogene (2018) Vol. 37, Iss. 27, pp. 3740-3752
Open Access | Times Cited: 108
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Jie Li, Xu Han, Xiaona Yu, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 107
Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma
L.X. Xu, Minghui He, Zihao Dai, et al.
Annals of Oncology (2019) Vol. 30, Iss. 6, pp. 990-997
Open Access | Times Cited: 107
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma
Johann von Felden, Amanda J. Craig, Teresa García‐Lezana, et al.
Oncogene (2020) Vol. 40, Iss. 1, pp. 140-151
Closed Access | Times Cited: 104
Immune evasion by cancer stem cells
Hiroyuki Tsuchiya, Goshi Shiota
Regenerative Therapy (2021) Vol. 17, pp. 20-33
Open Access | Times Cited: 98
Cellular heterogeneity and plasticity in liver cancer
Lo‐Kong Chan, Yu‐Man Tsui, Daniel Wai‐Hung Ho, et al.
Seminars in Cancer Biology (2021) Vol. 82, pp. 134-149
Open Access | Times Cited: 97
Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection
Pei Wang, Qianqian Song, Jie Ren, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 672
Closed Access | Times Cited: 43
Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers
Mahima Mishra, Rubai Ahmed, Deepak Kumar Das, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 8, pp. 4740-4756
Open Access | Times Cited: 16
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments
Claudia Campani, Sandrine Imbeaud, Gabrielle Couchy, et al.
Gut (2024) Vol. 73, Iss. 11, pp. 1870-1882
Closed Access | Times Cited: 12
Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts
De‐Zhen Guo, Xin Zhang, S Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinoma
Sana Rashid, Yingchuan Sun, Umair Ali Khan Saddozai, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 2, pp. 195-214
Open Access | Times Cited: 10
Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study
Charlotte K.Y. Ng, G.G. Di Costanzo, Nadia Tosti, et al.
Annals of Oncology (2018) Vol. 29, Iss. 5, pp. 1286-1291
Open Access | Times Cited: 81
IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma
Xiao Xiang, Ziyang Liu, Chong Zhang, et al.
Advanced Science (2021) Vol. 8, Iss. 17
Open Access | Times Cited: 47
Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study
Weiwei Zhai, Hannah Lai, Neslihan Arife Kaya, et al.
National Science Review (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 42
The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
Agnieszka Kopystecka, Rafał Patryn, Magdalena Leśniewska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9342-9342
Open Access | Times Cited: 21
Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis
Ruirui Zhao, Juhong Wu, Ling-Wu Tong, et al.
Journal of Colloid and Interface Science (2024) Vol. 660, pp. 257-276
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top